MedTrace Logo

Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs

NCT00050063 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2021-11-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether therapeutic HIV vaccines can help the immune system control HIV viral load after anti-HIV drugs are discontinued.

Conditions

  • HIV Infections

Interventions

BIOLOGICAL

Therapeutic vaccinations from A5058s

Participants will receive assigned interventions assigned in study A5058s.

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Spyros Kalamus, M. D. · Vanderbilt University Medical Center

  • Fred Valentine, M. D. · NYU MEDICAL CENTER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Completion
2004-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00050063 on ClinicalTrials.gov